Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3372PDF: 1978HTML: 7479 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1809PDF: 712HTML: 402 -
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1292PDF: 477HTML: 18612Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2199PDF: 1610HTML: 313 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2603PDF: 812HTML: 5230 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3176PDF: 1149HTML: 1500Untitled: 182Untitled: 173Untitled: 175 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1661PDF: 1250HTML: 265 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3223PDF: 786HTML: 2972Figure 1a and 1b: 153Figure 2: 163Figure 3: 181Figure 4: 164Figure 5: 167Tables 1-5: 156 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4355PDF: 1522HTML: 1555Untitled: 239 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3063PDF: 1031HTML: 3094 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2279PDF: 1167HTML: 649 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1406PDF: 700HTML: 1101Untitled: 186Untitled: 153Untitled: 136Untitled: 157Untitled: 165 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1402HTML: 475PDF: 834 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2436PDF: 1598HTML: 647 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2284PDF: 896HTML: 2006Fig 1 Rossi: 185 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1072PDF: 717HTML: 79 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2636PDF: 1631HTML: 2373Table1: 195 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3409PDF: 1300HTML: 1908Fig.1: 206Fig. 2: 216 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2955PDF: 1600HTML: 239 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2596PDF: 978HTML: 15118 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
991PDF: 541HTML: 728 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1417PDF: 1326HTML: 101 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1108PDF: 861HTML: 107 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1877HTML: 1479PDF: 1109







